All News from Accelerate Diagnostics

All News

Announcing New FDA Clearance for Accelerate PhenoTest® Improvements

Sep 16, 2020 — Accelerate Diagnostics today announced that the Company has received U.S. Food and Drug Administration (FDA) clearance for a new suite of product enhancements to the Accelerate Pheno® system to improve performance and expand the system’s antimicrobial susceptibility testing (AST) menu for bloodstream infections. The new release features improvements in susceptibility testing performance for four important […]

Continue reading ›

Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Individual IgM and IgG Antibody Tests

Sep 10, 2020 — Accelerate Diagnostics and BioCheck, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the individual BioCheck SARS-CoV-2 IgM Test Kit and the BioCheck SARS-CoV-2 IgG Test Kit. Today’s announcement follows the recent EUA approval of the fully automated MS-Fast instrument and the BioCheck SARS-CoV-2 IgM […]

Continue reading ›

Arizona Daily Star Covers New COVID-19 Tests from Accelerate Diagnostics
Arizona Daily Star Covers New COVID-19 Tests from Accelerate Diagnostics

Sep 03, 2020 — In an article released today, the Arizona Daily Star/Tucson.com covers the new COVID-19 testing solution offered by Accelerate Diagnostics under FDA Emergency Use Authorization. Read the full story here.

Continue reading ›

Accelerate Diagnostics Names Nedal Safwat Chief Strategy Officer
Accelerate Diagnostics Names Nedal Safwat Chief Strategy Officer

Aug 24, 2020 — Accelerate Diagnostics today announced that Nedal Safwat has been appointed its Chief Strategy Officer. Dr. Safwat has over 20 years of experience in the medical device, in vitro diagnostics, and life sciences industries. He previously served as the Executive Director of the ID/AST Franchise at bioMerieux.joins Accelerate from BioMerieux, where he served in multiple roles […]

Continue reading ›

Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System

Aug 18, 2020 — Accelerate Diagnostics and BioCheck, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the BioCheck SARS-CoV-2 IgM and IgG Combo Test and fully-automated Sophonix MS-Fast Automated Chemiluminescent Immunoassay Analyzing System. In accordance with the previously disclosed commercial supply and collaboration agreement, Accelerate Diagnostics will market, […]

Continue reading ›

University of Arkansas for Medical Sciences Study Featured in Contagion Article
University of Arkansas for Medical Sciences Study Featured in Contagion Article

Aug 14, 2020 — An article by Monica Mahoney, PharmD, was released yesterday on Contagion®. In the article, Mahoney reviews a University of Arkansas for Medical Sciences (UAMS) study by Dare, Lusardi, Pearson, et al., published in Clinical Infectious Diseases, which found that use of the Accelerate Pheno system enabled significant reductions time to first antibiotic intervention, times to […]

Continue reading ›

Antimicrobial Stewards from Tampa General Hospital see improvements after implementing Accelerate Pheno
Antimicrobial Stewards from Tampa General Hospital see improvements after implementing Accelerate Pheno

Jun 09, 2020 — Infectious Diseases Pharmacists from the antimicrobial stewardship team at Tampa General Hospital shared their process for evaluating and implementing new diagnostic technology to support efforts to improve sepsis outcomes and hospital length of stay, among other metrics at their hospital. Published in Pharmacy Purchasing & Products and Medical Lab Management, Drs. Ripal Jariwala, Nicholas Piccicacco, […]

Continue reading ›

Accelerate Diagnostics and BioCheck join the fight against COVID-19

Apr 15, 2020 — On April 15, 2020, Accelerate Diagnostics and BioCheck announced a commercial supply and collaboration agreement by which Accelerate will distribute the BioCheck MS-FAST system and BioCheck SARS-CoV-2 tests in North America, Europe, and the Middle East. The BioCheck MS-FAST system, a fully automated chemiluminescence immunoassay analyzer, and the BioCheck SARS-CoV-2 chemiluminescence-based tests are capable of […]

Continue reading ›

Clinicians at Moffitt Cancer Center make a difference for patients by optimizing antibiotic therapy earlier

Mar 06, 2020 — Mary Meyer, a transplant patient at Moffitt Cancer Center recently experienced first-hand how beneficial same-day antimicrobial susceptibility results can be. Ms. Meyer was treated in the Moffitt Urgent Care center for an unknown infection. Doctors there tested her blood using the Accelerate Pheno system, a new diagnostic system that can identify bacteria and provide antimicrobial […]

Continue reading ›

Accelerate Diagnostics Reports Fourth Quarter 2019 Financial Results

Feb 27, 2020 — Accelerate Diagnostics, Inc. announced financial results for the fourth quarter and full year ended December 31, 2019. “Our contracted instrument trajectory continued over the course of 2019 as we doubled our global contracted instrument base by signing 304 instruments, including 137 units during the fourth quarter. Our full-year revenue was short of expectations as multi-site […]

Continue reading ›